These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 35342698

  • 1. Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study.
    Kuswiyanto RB, Gunawijaya E, Djer MM, Noormanto, Rahman MA, Murni IK, Sukardi R, Utamayasa A, Ardiansyah R, Nova R, Liliyanti S, Rahayuningsih SE, Anggriawan SL, Rahayuningsih TY, Koentartiwi D, Soewarniaty R, Yantie VK, Nugroho S, Hidayat T, Ontoseno T, Tobing TC, Ali M, Bashari MH, Yosy DS, Arafuri N, Hilmanto D, Yanuarso PB, Advani N, Sastroasmoro S, Putra ST.
    Glob Heart; 2022; 17(1):15. PubMed ID: 35342698
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: Midterm outcomes of the first middle-eastern experience.
    Haddad RN, Daou LS, Saliba ZS.
    Catheter Cardiovasc Interv; 2020 Sep 01; 96(3):E295-E302. PubMed ID: 31886940
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children.
    Liu S, Zhang W, Li J, Wang S, Qian M, Shi J, Xie Y, Zhang Z.
    J Interv Cardiol; 2021 Sep 01; 2021():4091888. PubMed ID: 34621141
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of Amplatzer duct occluder II and konar-MF™ VSD occluder in the closure of perimembranous ventricular septal defects in children weighing less than 10 kg.
    Yildiz K, Narin N, Oksuz S, Ozdemir R, Pamukcu O, Baykan A, Ozyurt A, Bagli S, Aktas R, Safak IN, Atlan MA, Bayam YS, Karadeniz C.
    Front Cardiovasc Med; 2023 Sep 01; 10():1255808. PubMed ID: 38094116
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter Ventricular Septal Defect Closure with Lifetech™ Konar-MF Occluder in Infants Under 10 kg with Only Using Venous Access.
    Ece İ, Bağrul D, Kavurt AV, Terin H, Torun G, Koca S, Gül AEK.
    Pediatr Cardiol; 2024 Jan 01; 45(1):175-183. PubMed ID: 38081968
    [Abstract] [Full Text] [Related]

  • 6. Midterm Results of Transaxillary Occluder Device Closure of Perimembranous Ventricular Septal Defect Guided Solely by Transesophageal Echocardiography.
    Liang W, Zhou S, Fan T, Song S, Li B, Dong H, Zhang L, Hu M, Liu L.
    Heart Surg Forum; 2019 Mar 08; 22(2):E112-E118. PubMed ID: 31013220
    [Abstract] [Full Text] [Related]

  • 7. Transcatheter Closure of Perimembranous Ventricular Septal Defect Using KONAR-MF™: A Multicenter Experience.
    Koneti NR, Azad S, Bakhru S, Dhulipudi B, Sitaraman R, Kumar RK.
    Pediatr Cardiol; 2024 Apr 30. PubMed ID: 38689022
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occluder: initial and short-term multi-institutional results.
    Sadiq M, Qureshi AU, Younas M, Arshad S, Hyder SN.
    Cardiol Young; 2022 May 30; 32(5):755-761. PubMed ID: 34318740
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter Device Closure of Perimembranous and Intracristal Ventricular Septal Defects in Children: Medium- and Long-Term Results.
    Jiang D, Han B, Zhao L, Yi Y, Zhang J, Fan Y, Lv J, Wang J, Wang Y.
    J Am Heart Assoc; 2021 Jun 30; 10(11):e020417. PubMed ID: 33998288
    [Abstract] [Full Text] [Related]

  • 10. Perventricular closure of perimembranous ventricular septal defects using the concentric occluder device.
    Wang S, Zhuang Z, Zhang H, Zhen J, Lu Y, Liu J, Xu Z.
    Pediatr Cardiol; 2014 Apr 30; 35(4):580-6. PubMed ID: 24196912
    [Abstract] [Full Text] [Related]

  • 11. Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Lê VSD Coil: A French multicentre study.
    Houeijeh A, Godart F, Jalal Z, Ovaert C, Heitz F, Mauran P, Baruteau AE, Guirguis L, Hadeed K, Baudelet JB, Iriart X, Aldebert P, Acar P, Fraisse A, Odemis E, Karsenty C, Thambo JB, Hascoët S.
    Arch Cardiovasc Dis; 2020 Feb 30; 113(2):104-112. PubMed ID: 31982353
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder.
    Zhou D, Pan W, Guan L, Ge J.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):666-74. PubMed ID: 22109986
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
    Zhao PJ, Yu ZQ, Gao W, Li F, Fu LJ, Liu TL, Li Y, Zhang YQ, Huang MR, Guo Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct 01; 40(10):817-20. PubMed ID: 23302666
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter Closure of Perimembranous Ventricular Septal Defects Including Multifenestrated and Gerbode-Type Defects Using the Lifetech Konar Device.
    Godart F, Baudelet JB, Delarue A, Polge AS, Domanski O, Bichali S, Houeijeh A.
    J Clin Med; 2023 Oct 05; 12(19):. PubMed ID: 37835013
    [Abstract] [Full Text] [Related]

  • 15. Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: A multicentre study.
    Tanidir IC, Baspinar O, Saygi M, Kervancioglu M, Guzeltas A, Odemis E.
    Int J Cardiol; 2020 Jul 01; 310():43-50. PubMed ID: 32122701
    [Abstract] [Full Text] [Related]

  • 16. Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder.
    Lee SM, Song JY, Choi JY, Lee SY, Paik JS, Chang SI, Shim WS, Kim SH.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):1141-6. PubMed ID: 23554093
    [Abstract] [Full Text] [Related]

  • 17. Three centers experience with device closure of congenital Gerbode-type perimembranous ventricular septal defects.
    Haddad RN, Boudjemline Y, Combes N, Hadeed K, Karsenty C, Saliba Z.
    J Card Surg; 2022 Sep 01; 37(9):2714-2724. PubMed ID: 35771212
    [Abstract] [Full Text] [Related]

  • 18. Effect of transcatheter closure by AmplatzerTM Duct Occluder II in patients with small ventricular septal defect.
    Wongwaitaweewong K, Promphan W, Roymanee S, Prachasilchai P.
    Cardiovasc Interv Ther; 2021 Jul 01; 36(3):375-383. PubMed ID: 32462466
    [Abstract] [Full Text] [Related]

  • 19. Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO).
    Odemis E, Kizilkaya MH.
    Cardiol Young; 2023 Oct 01; 33(10):2021-2026. PubMed ID: 36380499
    [Abstract] [Full Text] [Related]

  • 20. Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience.
    Udink Ten Cate FEA, Sobhy R, Kalantre A, Sachdev S, Subramanian A, Koneti NR, Kumar RK, Hamza H, Jayranganath M, Sreeram N.
    Catheter Cardiovasc Interv; 2019 Jan 01; 93(1):82-88. PubMed ID: 30208249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.